Sedimentum secures investment

The Zug-based HealthTech start-up Sedimentum has successfully raised a total of 2.1 million Swiss francs as part of an oversubscribed seed financing round. In so doing, the start-up is now “well positioned to conquer the DACH market with its smart fall detection technology”, according to a press release.

The investors included the Innovation Fund Association of the Alternative Bank Switzerland, the Antoine Blättler Foundation in addition to national and international business angels, an investment firm and a family office. “This oversubscribed seed financing round is confirmation of our actions up to now, our corporate values and our vision, while also sending out a clear signal”, according to Sandro Cilurzo, founder and CEO of Sedimentum.

Following the financing round, Sedimentum has added three members to its Board of Directors: Iris Welten, former CEO of the investment and innovation promotion agency Basel Area Business & Innovation and board member of a care home, Stefan Buser, erstwhile CFO of SENIOcare Schweiz, and Marcel Dürr, co-founder and Chairman of the Board of Parallel Informatik AG.

The Sedimentum sensor, which can be attached to ceilings, for example, uses an Artificial Intelligence (AI) algorithm to detect irregularities such as falls. In such cases, care workers in psychiatric clinics, nursing homes or private apartments are alerted, which means that the necessary measures can be initiated without any further delay.

Sedimentum cites data protection as a unique selling point and innovation driver. For this reason, Cilurzo and his team developed a fall detector without cameras and microphones. An innovative data anonymization process protects the interests of institutions as well as those at risk of falling. “From a legal point of view, our solution is completely anonymous”, explains Sandro Cilurzo, who previously worked as an IT security officer at a large psychiatric clinic. He adds: “The solution therefore offers our customers clear added value and is set to become a gamechanger on the healthcare market”.